by Richard Daverman, PhD
January 14, 2013 -- China National Biotech, the largest biotech in China, is once again reported to be planning a Hong Kong IPO, though the company has not made a formal announcement of the transaction. According to sources, the IPO will raise $1.5 billion. The tentative scheduling is for CNBG to file by the end of March, with the actual transaction taking place in Q2 or Q3. The mammoth IPO has been a feature of the rumor mill for well over a year. More details....
